[Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience]. (1993)

Peer-Reviewed Study · Mohr H, Pohl U, Lambrecht B, Wieding JU, Schmitt H · June 1993

Mohr H et al., 1993-06: German 1993 report on production and clinical experience of methylene-blue/light virus inactivation of single-donor plasma, giving the standard conditions (1 microM methylene blue, 1 h illumination, about 50,000 lx) and reporting treated plasma as well tolerated as conventional FFP.

Under the chosen conditions (1 microM methylene blue, 1 h illumination time, about 50,000 lx), the increase is approximately 25%.

19-24

Mohr H et al., 1993-06: German 1993 report on production and clinical experience of methylene-blue/light virus inactivation of single-donor plasma, giving the standard conditions (1 microM methylene blue, 1 h illumination, about 50,000 lx) and reporting treated plasma as well tolerated as conventional FFP. C5 Germany (Infusionsther Transfusionsmed 20 Suppl 2:19-24). Study type: production/technical report plus drug-monitoring clinical study; patient numbers not in the abstract. Methylene blue 1 microM, visible light 1 h, ~50,000 lx. Comparator: conventional fresh-frozen plasma. Funder/conflicts not stated. This is the technical basis of the German methylene-blue plasma procedure later taken up in other countries. Study type: uncontrolled series.